Samsung Biologics Co.,Ltd.
207940Biotechnology
₩1,366,000.00−0.44%As of Oct 29vs prior close
- Market cap
- $47.6B
- P/E (TTM)
- 34.4×
- P/E (FY1)
- 35.5×
- From 52W high
- −30.48%
- EPS (LTM)
- ₩39,724.83
- Revenue (LTM)
- ₩5.1T
- Net margin
- 38.75%
Nomior Score
39
Steady ProfileBottom 27% of the scored universe
Growth62
Quality65
Value39
Momentum7
Resilience49
Growth
+14.94%revenue a year over 3 fiscal years
YE22 ₩3TLTM ₩5.1T
Connections
Revenue to profitYE25
39% of revenue became net profit, up 8 pts on a year.